Acino

Acino is a commercial-stage pharmaceutical company with a dual business model: marketing branded and generic medicines in targeted emerging markets and providing contract manufacturing services for complex oral solid dose formulations. The company is part of Arcera, a global life sciences platform backed by Abu Dhabi's ADQ, providing strategic and financial support. With over 50 years of manufacturing experience, a commercial footprint across four continents, and a focus on advanced drug delivery, Acino positions itself as a reliable partner for expanding access to quality medicines in high-growth regions.

Specialist in Oral Solid Dose (OSD) manufacturing, with expertise in complex modified release formulations, dispersible systems, Multi-Unit Pellet System (MUPS), and minitablets.

Acino competes with other multinational generic and specialty pharma companies (e.g., Teva, Sandoz, Viatris) in emerging markets, as well as regional local players. Its competitive edge is its focused commercial footprint in specific regions, Swiss-quality manufacturing reputation, and advanced OSD formulation expertise, which differentiates it from standard generic manufacturers.